Not on air · 2 of 3 networks checked
Accord BioPharma
- accordbiopharma.com
- Healthcare & Life Sciences
- US
- 137 employees
Accord BioPharma’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 40. Watch Accord BioPharma with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksNov 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 1 Nov 2026 | See all 40 ads → | ||
| Meta | Not checked | — | |||
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 29 Oct 2026 | Collect them with the API → |
Accord BioPharma has no live LinkedIn ads. We recorded no Google ads on 29 Oct 2026.
Latest ads
- LINKEDIN · IMAGERecorded 31 Aug 2026
Meet Accord: Our first biosimilar in immunology has National Preferred Formulary placement through one of the nation's largest PBMs. We're offering a treatment option for certain immune-mediated conditions - with more affordability and the access your members need.
- LINKEDIN · VIDEORecorded 31 Aug 2026
Meet Accord: Our first biosimilar in immunology has National Preferred Formulary placement through one of the nation's largest PBMs. We're offering a treatment option for certain immune-mediated conditions - with more affordability and the access your members need.
- LINKEDIN · VIDEORecorded 31 Aug 2026
Accord BioPharma's biosimilar for certain immune-mediated conditions is now covered on one of the nation's largest preferred formularies – and we're just getting started. With one of the industry's deepest pipelines and a commitment that goes beyond biology, we're transforming biosimilar access nationwide.
- LINKEDIN · IMAGERecorded 31 Aug 2026
Accord BioPharma's biosimilar for certain immune-mediated conditions is now covered on one of the nation's largest preferred formularies – and we're just getting started. With one of the industry's deepest pipelines and a commitment that goes beyond biology, we're transforming biosimilar access nationwide.
- LINKEDIN · VIDEORecorded 31 Aug 2026
Accord is proud to partner with a leading PBM. We are committed to providing comprehensive patient support from education to financial assistance to make transformation possible in immunology.
- LINKEDIN · VIDEORecorded 31 Aug 2026
We're striving to eliminate barriers to access by launching our immunology biosimilar with comprehensive support included and placement on a major National Preferred Formulary.
6 of 40 adsSign up to see every Accord BioPharma ad, filter by format and date, and get alerts on new ones.
See all 40 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.